Life Sciences and Healthcare

Evolution of Health Technology Assessment (HTA) in China

Asian pharma markets have been in the limelight for some time now for increasingly dynamic drug policies, expanding coverage, increasing affordability and potential economies of scale. While Indonesia and the Philippines are striving towards universal healthcare coverage, South Korea and Taiwan are focusing on managed entry agreements. China is not behind in the race with […]

Moving Forward From Medicare Part D Rebate Reform

Moving Forward From Medicare Part D Rebate Reform: Pricing Transparency and What it Means for Patients, Providers, and Life Sciences Companies Last week’s announcement from the Trump administration that it was abandoning its Medicare Part D and Medicaid rebate reform efforts was a surprise but the debate over point-of-sale (POS) discounting and drug pricing transparency […]

Aiming at world pharma stage, China embraces regulatory reforms

With the deepening of the reform of its pharmaceutical industry in the past few years, since joining the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), China has added or amended more and more laws and regulations to meet the needs of the world’s drug developers. During DIA China 2019 […]

Category management: the key to collaboration?

Sourcing and purchasing departments should function symbiotically—two parts of procurement whole. However, many organizations find that the alignment is not as strong as they would hope, which has led to some self-reflection on the best way to build symmetry into the departments. This can come down to a question of philosophy. What are your organization’s […]

The AbbVie-Allergan Acquisition and the Road Ahead

Have allergan’s CNS and ophthalmology franchises been underestimated? AbbVie’s long-term growth strategy finally shapes up with the acquisition of Allergan. The acquisition gives an immediate scale and profitability to AbbVie’s growth, bringing new therapeutic segments which include Allergan’s leading medical aesthetic business. AbbVie’s strategic portfolio diversification was widely anticipated to minimize its overt dependence on […]

Renal Denervation is Making a Comeback – What You Need to Know

In the latest post of this series, we provided an overview on the story of renal denervation and an update on the latest developments in this technology. In brief, though results from the Symplicity HTN-3 trial were disappointing and led to a pause on progress in this field in 2014, more recent clinical trials demonstrating […]

Record new drug approvals: ‘fleeting success’ or here to stay?

With a record 59 new drugs approved by the FDA and 42 new active substances recommended for authorization by the European Medicines Agency, 2018 was a profoundly productive year for biopharma. In a new analysis, Jamie Munro and Helen Dowden from Clarivate Analytics examine whether 2018 represents “a fleeting success” or if there are underlying […]

Record new drug approvals: ‘fleeting success’ or here to stay?

With a record 59 new drugs approved by the FDA and 42 new active substances recommended for authorization by the European Medicines Agency, 2018 was a profoundly productive year for biopharma. In a new analysis, Jamie Munro and Helen Dowden, of Clarivate Analytics, examine whether 2018 represents “a fleeting success” or if there are underlying changes […]

Intermountain Plays Pivotal Role in Optum-DaVita Deal

In a big healthcare merger or acquisition, sometimes the divestitures required for regulatory muster tell a more interesting story. In OptumHealth’s purchase of DaVita Medical Group’s practices, Intermountain Healthcare taking on DaVita’s Nevada operations might be the most curious piece. The deal impacts DaVita’s large medical groups in California, Colorado, Florida, Nevada, New Mexico, and […]

HealthHUBs: CVS-Aetna’s Expansion Into Primary-Care a Major Disruptor

HealthHUBs: CVS-Aetna’s Expansion Into Primary-Care a Major Disruptor   Shortly after CVS Health merged with Aetna in November 2018, CVS Health announced the debut of its “HealthHUB” concept stores in Houston. These stores, which feature up to 80 percent of the primary-care scope (barring physicians) plus expanded staff and durable medical equipment, position CVS to […]